The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS
Clinical trial NCT04391361 · UNKNOWN
Trial details
- NCT number
- NCT04391361
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.